IGA OF SERUM GLOBULINS AND EXTERNAL SECRETIONS
血清球蛋白和体外分泌物的 IGA
基本信息
- 批准号:3156043
- 负责人:
- 金额:$ 24.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1981
- 资助国家:美国
- 起止时间:1981-12-01 至 1986-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This grant has supported our long-term efforts to characterize the
secretory immune system. We have attempted to elucidate the nature of the
cells and molecules involved and the detailed mechanisms by which their
interactions at the mucosal level equip the host for its continuing
conflict with potentially harmful environmental agents. Studies on mucosal
immunity have a wide range of medical implications. For example, in
resistance and immunoprophylaxis against infectious and allergic diseases,
many of which primarily affect mucous membranes. Specifically, we will
investigate the following: How B cells in Peyer's patches (PP) become
committed to IgA. Ig class switching will be studied using reverse plaque,
radioimmunoassay, and at the molecular level with cDNA probes for the
various CH genes. Attempts will be made to induce switching from CMu to
CAlpha with T cell factors, FcAlpha Fragments and anti-Ig. The
characteristics of accessory cells in the PP will be assessed using
monoclonal antibodies to macrophages and dendritic cells, antigen specific
T cell clones and alloreactive T cell lines. We will explore the
mechanisms by which orally administered antigens result in the concurrent
induction of secretory antibodies and systemic suppression (oral
tolerance). The genetic regulation of oral tolerance and the role of
isotype specific Ts for IgG, TH for IgA and soluble factors derived from
these cells will be studied. A model for IgA deficiency in mice (anti-IgA
in vivo) will be used to investigate the role of the secretory system in
oral tolerance and in regulating the absorption of ingested antigens. We
will explore whether oral immunization with tumor cells (with and without
inter-leukin-2) leads to cytotoxic T cells and tumor immunity. Studies
are outlined on the IgA and secretory immune responses in the neonate and
CBA/N mice. Neonatal mice will be reconstituted with various cell
preparations including those enriched in accessory cells to determine the
effect on the ontogeny of the IgA response. Finally, T cell "homing" to
the gut and distal mucosal sites (using 126IUDR labeled T cells from
various sources) will be employoed in normal, irradiated and nude/nude mice
to determine if T cells influence the migration patterns of B cells.
这笔拨款支持了我们的长期努力
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS B TOMASI其他文献
THOMAS B TOMASI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS B TOMASI', 18)}}的其他基金
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
癌症治疗和疫苗方案中免疫基因的表观遗传调控
- 批准号:
8109305 - 财政年份:2008
- 资助金额:
$ 24.19万 - 项目类别:
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
癌症治疗和疫苗方案中免疫基因的表观遗传调控
- 批准号:
7694348 - 财政年份:2008
- 资助金额:
$ 24.19万 - 项目类别:
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
癌症治疗和疫苗方案中免疫基因的表观遗传调控
- 批准号:
7528791 - 财政年份:2008
- 资助金额:
$ 24.19万 - 项目类别:
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
癌症治疗和疫苗方案中免疫基因的表观遗传调控
- 批准号:
7884612 - 财政年份:2008
- 资助金额:
$ 24.19万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 24.19万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 24.19万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 24.19万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 24.19万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 24.19万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 24.19万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 24.19万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 24.19万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 24.19万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 24.19万 - 项目类别:
Discovery Grants Program - Individual